HIV Glasgow 2018
The 2018 International Congress on Drug Therapy in HIV Infection (HIV Glasgow 2018) was held in Glasgow, UK, from 28 to 31 October 2018.
-
28-31 October 2018
-
Glasgow UK
High prevalence of diabetes and pre-diabetes in people at London HIV clinics
How has Glasgow responded to an outbreak of HIV among people who inject drugs?
Fostemsavir, novel gp120 inhibitor, salvages nearly half of people with no other treatment options left
Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant people shows
How safe is PrEP? Meta-analysis finds no increased risk of serious side-effects
Hepatitis C increases the risk of premature delivery for pregnant women with HIV
Dolutegravir or lower-dose efavirenz equally effective, but less resistance with dolutegravir
Bictegravir matches dolutegravir in first-line treatment
Neural tube defects and integrase inhibitors: studies show no further evidence of increased risk
Two-drug protease inhibitor treatment as effective as three-drug treatment – and fewer stop due to side-effects
Generic PrEP bought online has correct amounts of emtricitabine and tenofovir